Page 11 - Sirnaomics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sirnaomics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sirnaomics Inc Today - Breaking & Trending Today

Sirnaomics to Present at Medical Dermatology Summit


Sirnaomics to Present at Medical Dermatology Summit
News provided by
Share this article
, a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, today announced that it will be presenting results from a recently completed Phase 2a clinical study of the company s lead drug candidate, STP705, for treatment of squamous cell skin cancer, at the 19th Annual South Beach Symposium Medical Dermatology Summit. The virtual conference runs from Feb. 5-7, 2021.
Title: Innovation in the Treatment of NMSC: siRNA STP705 for SCC in situ
Presented by: Mark Steven Nestor, M.D., Ph.D.; Director, Center for Cosmetic Enhancement, Center for Clinical and Cosmetic Research in Aventura, Florida ....

United States , South Beach , Mark Steven Nestor , Mark Corbae , Stephanie Carrington , Michael Molyneaux , Research In Aventura , Sirnaomics Inc , Annual South Beach Symposium Medical Dermatology , Cosmetic Enhancement , Cosmetic Research , Orphan Drug Designations , Global Vision , Patient Centered , Medical Officer , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு கடற்கரை , குறி ஸ்டீவன் கூடு , மாற்றாந்தாய் கேரிங்டன் , மைக்கேல் மோலிநி , ஆராய்ச்சி இல் அவெண்டுறை , ஆண்டு தெற்கு கடற்கரை சிம்போசியம் மருத்துவ தோல் நோய் , ஒப்பனை விரிவாக்கம் , ஒப்பனை ஆராய்ச்சி , உலகளாவிய பார்வை , நோயாளி மையமாக ,

First patient dosed with Sirnaomics' cancer drug candidate – Maryland Daily Record

First patient dosed with Sirnaomics' cancer drug candidate – Maryland Daily Record
thedailyrecord.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thedailyrecord.com Daily Mail and Mail on Sunday newspapers.

Sirnaomics Inc ,